---
url: https://www.servicesaustralia.gov.au/sites/default/files/2025-10/pb113-2511en-f.pdf
title: Severe chronic plaque psoriasis - continuing authority application
scrapedAt: 2026-02-16T22:09:24.463Z
source: servicesaustralia.gov.au
---
# Severe chronic plaque psoriasis – continuing authority application

# Online PBS Authorities

Requesting PBS Authorities online provides an immediate assessment in real time.

For more information and how to access the Online PBS Authorities system, go to servicesaustralia.gov.au/hppbsauthorities

When to use this form

Use this form to apply for continuing PBS-subsidised biological medicines for patients 18 years or over with severe chronic plaque psoriasis.

Important information

Continuing authority applications can be made in real time using the Online PBS Authorities system or in writing and must include sufficient information to determine the patient’s eligibility according to the PBS criteria.

Applications for balance of supply can be made in real time using the Online PBS Authorities system or by phone. Call 1800 700 270 Monday to Friday, 8 am to 5 pm, local time.

Under no circumstances will phone approvals be granted for severe chronic plaque psoriasis continuing authority applications.

Where the term ‘biological medicine’ appears, it refers to adalimumab, bimekizumab, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, secukinumab, tildrakizumab and ustekinumab.

A copy of the PASI calculation sheets is provided for your convenience.

The information in this form is correct at the time of publishing and may be subject to change.

# Continuing treatment

This form is ONLY for continuing treatment.

The patient remains eligible to receive continuing treatment providing they continue to sustain a response to treatment.

After an authority application for the first continuing treatment has been approved, subsequent continuing treatments with PBS-subsidised biosimilar brands of biological medicines are Authority Required (STREAMLINED) and do not require authority approval from Services Australia for the listed quantity and repeats.

Continuing treatment with PBS-subsidised infliximab s.c. is Authority Required (STREAMLINED) and does not require authority approval from Services Australia for the listed quantity and repeats.

Section 100 arrangements for infliximab i.v.

This item is available to a patient who is attending:

an approved private hospital, or • a public hospital

and is a:

• day admitted patient • non-admitted patient, or • patient on discharge.

This item is not available as a PBS benefit for in-patients of a public hospital.The hospital name and provider number must be included in this authority form.

# Treatment specifics

The assessment of the patient’s response to the course of treatment must be conducted within the time frame specified in the restriction. Where a demonstration of response is not conducted within the required time frame, the patient will be deemed to have failed treatment with that particular PBS-subsidised biological medicine.

A patient who has experienced a serious adverse reaction of a severity necessitating permanent treatment withdrawal is not considered to have failed treatment with that particular PBS-subsidised biological medicine.

# For more information

Go to [www.servicesaustralia.gov.au/healthprofessionals](http://www.servicesaustralia.gov.au/healthprofessionals)

# Severe chronic plaque psoriasis – continuing authority application

# Online PBS Authorities

You do not need to complete this form if you use the Online PBS Authorities system.

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/9bc5b77379e6383036be387568474348d4e9b10d26322aac02af9c8348b4ab88.jpg)

Go to [www.servicesaustralia.gov.au/hppbsauthorities](http://www.servicesaustralia.gov.au/hppbsauthorities)

# Patient’s details

1 Medicare card number

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/44403020a8ff12950bd0676ca651e6d28dc0c37d088bb51d1d7626d5ef24e1ce.jpg)

or Department of Veterans’ Affairs card number

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/9f0a6979147682dbe83be5e9f57c815e888a119c2fc416eca16c35f74c62b1ca.jpg)

2 Family name

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/9f5b8bd9412489236c432345a03c1a320cb5b9a31066ed628d45674f7a5011de.jpg)

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/ac917493ca8b25a9db0f9449f828f03eabf0836b7eb3f139deee1164323efeda.jpg)

3 Date of birth (DD MM YYYY)

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/dcc0748e7208eb73996c775c814332ff9beced1ee3aedae69de115b3343cad44.jpg)

4 Patient’s weight

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/067cb17aaa82d2b91f44cf8b76ed47f4a4b1f51c5e88231165b700e472564831.jpg)

# Prescriber’s details

5 Prescriber number

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/d1227f3fc7085f556aa2733d8c8aa6419e63e0e876f7ed1bdb08a8c8b631ea71.jpg)

6 Family name

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/eb3d7e6e4c15f27dd5b05c06e50c58543f47798940efc5bfac670a1debb04539.jpg)

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/dfdf95ef5953518d9728b6fcb2488769005205b80e2124cbdfbb3dffd2fe17d8.jpg)

7 Business phone number (including area code)

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/a33f0fd43c9b14da41bada04c1949b0da2132bc3d519c6de2125b748c819020c.jpg)

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/111c527495979ec818c9dcbd284db8f7f75f35bc3021af9704302fd228724add.jpg)

# Hospital details

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/f3ce0bebe18568d14e709a047877840772d1977610cfbc3f28852b43d4828e1e.jpg)

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/b3272017f63edcf93014f5f52586c0fe7956698b08269e134ccee9dcb55da4e2.jpg)

9 Hospital provider number

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/1c357858f12c3a1ca79e5a83f864e7bfe7c4e868912f86f98a1685582717c671.jpg)

# Conditions and criteria

To qualify for PBS authority approval, the following conditions must be met.

10 Is the patient being treated by a dermatologist?

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/8c0db3bdef5ad5d2703dcad4d8d43b7d454f2794436b764005762b7c035362a1.jpg)

11 This application is for the:

first continuing treatment with:

adalimumab

etanercept

infliximab i.v. (at a dose of 5mg/kg)

ustekinumab

# or

subsequent continuing treatment with:

adalimumab

etanercept

infliximab i.v. (at a dose of 5mg/kg)

ustekinumab

# or

continuing treatment with:

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/07a21a39b5d6ef403fdae17589dd568ab165c852b182de49874d149f81e65efc.jpg)

12 Has the patient received this drug (regardless of formulation) as their most recent course of PBS-subsidised biological medicine treatment for this condition?

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/677c66b23d582d997a12251f6bc00e678fb037e390de1a9f09b60462448172a1.jpg)

13 Is this treatment systemic monotherapy (other than methotrexate)?

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/8b64741cb73a71c7a4dbf3ce21f66f6cc5e7e6de72839285ff3e8045117f846f.jpg)

14 Has the assessment of response been conducted following a minimum of 12 weeks of therapy and no later than 4 weeks from cessation of the most recent course of treatment?

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/a81a75e200949b2fe315f14c4b7292830affe6dfe5e611b2378b313ddfa7fda3.jpg)

Go to 16

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/ab09cc96c21538fefde4cf694c3672212167a3ba0f2a4a74cf599de308b7e337.jpg)

Go to 17

16 The patient has demonstrated an adequate response to treatment with this drug evidenced by a Psoriasis Area and Severity Index (PASI) score reduced:

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/a7fa337933a9d6515e6acfd387de92b0f4da3bba7bb83c52d82fa50a798b0e98.jpg)

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/bcd04e0fcb5a4400575dcee93d01094b30887959bc48b53a2d8379dbacd76139.jpg)

Go to 21

17 The patient has demonstrated an adequate response to treatment with this drug evidenced by a reduction:

in the PASI symptom subscores for all 3 of erythema, thickness and scaling, to slight or better, or sustained at this level, as compared to the baseline values

Go to 18

# or

to $7 . 5 %$ or less in the skin area affected Go to 19

# or

by at least $7 5 %$ in the skin area affected, or sustained at this level, as compared to the baseline value for this treatment cycle

18 Response assessments have been performed on the same affected area assessed at baseline, with the area being:

(Select one responding area only with all 3 subscores reduced to 0 or 1)

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/c302fef00f19fb94f82b0fe290a9e440deea014c84d445e9e6e0a53b0873e7ac.jpg)

Provide responding PASI symptom subscores for that area

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/61fe1c0cb4f9008c27100e9b9ebd126984315fa4f1a7bfe28afad8b300a1ffda.jpg)

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/78ebe478f4bb56c530765efd2168d96f02b58992fae29029c0fa52e2b379c015.jpg)

Go to 21

19 Response assessments have been performed on the same affected area assessed at baseline, with the area being:

(Select one responding area only with skin area affected reduced to $7 . 5 %$ or less)

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/122fec8583f73188dce8fff061c9e4aaeff9c109a196ab7998c2ba3a99606b47.jpg)

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/15bb482ea434673a893b33d68362f36619a46ec979f5e4b46a58f2bd2f55da6e.jpg)

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/ec051ced949766dc98149b959922b17244507eedcaa0d8c7727181b64574036c.jpg)

Go to 21

20 Response assessments have been performed on the same affected area assessed at baseline, with the area being: (Select one responding area only reduced by at least $7 5 %$ from baseline)

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/4e7a99a212e90881fa16ca6446e3e7aa63b5c7d95c1e16fa225b01898b5602fe.jpg)

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/96a2687115d362a7739f4d9da90a0a7ef7d0db51512e764492186a59886787ab.jpg)

Responding numerical $%$ for that same area

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/791d00563f7a5d26fa3b85dbe6a22307b4a6003af78f2563cc63787b832e1e8e.jpg)

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/9d96ee57aa4b03d961beb51416f696158120c7311aacdba6de234fe16bca4e3d.jpg)

# Checklist

21

The relevant attachments need to be provided with this form.

Details of the proposed prescription(s).

The completed PASI calculation sheet(s).

# Privacy notice

22 Personal information is protected by law (including the Privacy Act 1988) and is collected by Services Australia for the purposes of assessing and processing this authority application.

Personal information may be used by Services Australia, or given to other parties where the individual has agreed to this, or where it is required or authorised by law (including for the purpose of research or conducting investigations).

More information about the way in which Services Australia manages personal information, including our privacy policy, can be found at [www.servicesaustralia.gov.au/privacypolicy](http://www.servicesaustralia.gov.au/privacypolicy)

# Prescriber’s declaration

You do not need to sign the declaration if you complete this form using Adobe Acrobat Reader and return this form through Health Professional Online Services (HPOS) at

[www.servicesaustralia.gov.au/hpos](http://www.servicesaustralia.gov.au/hpos)

# 23 I declare that:

I am aware that this patient must meet the criteria listed in the current Schedule of Pharmaceutical Benefits to be eligible for this medicine I have informed the patient that their personal information (including health information) will be disclosed to Services Australia for the purposes of assessing and processing this authority application • I have provided details of the proposed prescription(s) and the relevant attachments as specified in the Pharmaceutical Benefits Scheme restriction the information I have provided in this form is complete and correct.

# I understand that:

giving false or misleading information is a serious offence.

I have read, understood and agree to the above.

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/fcc444ff6df7e5ed09412bb677088802c9b8a3be787aca7d5509d26b36caf476.jpg)

Prescriber’s signature (only required if returning by post)

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/6ac9698ee9170fd5f6e2a3e1e5de04a818e5bc91bc802df392e28d68c0807b04.jpg)

# Returning this form

Return this form, details of the proposed prescription(s) and any relevant attachments:

• online (no signature required), upload through HPOS at [www.servicesaustralia.gov.au/hpos](http://www.servicesaustralia.gov.au/hpos) or

• by post (signature required) to Services Australia Complex Drugs Programs Reply Paid 9826 HOBART TAS 7001

# PASI calculation and body diagram – face, hand and foot

Mark clearly on the diagrams the extent of the affected area(s)

|     |     |     |     |     |     |
| --- | --- | --- | --- | --- | --- |
| Body region |
| Indicate the degree ofinvolvement of the bodyregion surface as apercentage | FACE | RIGHT PALM | LEFT PALM | RIGHT SOLE | LEFT SOLE |
| % | % | % | % | % |
| ORCaicopatient's skin condition (circle one number in each box) |
| Erythema | 0 = none1 = slight | 0 = none1 = slight | 0 = none1 = slight | 0 = none1 = slight | 0 = none1 = slight2 = moderate3 = severe4 = very severe |
| 2 = moderate3 = severe4 = very severe | 2 = moderate3 = severe4 = very severe | 2 = moderate3 = severe4 = very severe | 2 = moderate3 = severe4 = very severe |
| Thickness | 0 = none1 = slight2 = moderate3 = severe4 = very severe | 0 = none | 0 = none | 0 = none | 0 = none1 = slight2 = moderate3 = severe4 = very severe |
| 1 = slight | 1 = slight2 = moderate | 1 = slight2 = moderate3 = severe4 = very severe |
| 2 = moderate |
| 3 = severe4 = very severe | 3 = severe4 = very severe |
| Scaling | 0 = none | 0 = none | 0 = none | 0 = none | 0 = none1 = slight2 = moderate3 = severe4 = very severe |
| 1 = slight | 1 = slight | 1 = slight | 1 = slight |  |
| 1 = slight2 = moderate |
| 2 = moderate | 2 = moderate | 2 = moderate |
| 3 = severe | 3 = severe | 3 = severe | 3 = severe |
| 4 = very severe | 4 = very severe | 4 = very severe | 4 = very severe |

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/4a2e5dc23932c48017a3cda5b30ec485bfb28e3bbf62b9734f099f1a48ddc73d.jpg)

# PASI calculation and body diagram – whole body

|     |     |     |     |     |     |
| --- | --- | --- | --- | --- | --- |
| Plaque characteristic | Rating score | Body region (and weighting factor) |
| Head | Upper Limbs | Trunk | Lower Limbs |
| Erythema | 0 = None1 = Slight2 =Moderate3 Severe4 = Very severe |  |  |  |  |
| Thickness |  |  |  |  |
| Scaling |  |  |  |  |
| Add together each of the 3 scores for each of the body regions to give 4 separate sub totals. |
| Sub TotalsA1= | A2= A3= A4= |
| Mtplower limbs to give a value B1, B2, B3 and B4 for each body region respectively |
|  | A1 x 0.1 = B1 | A2 x 0.2 = B2 | A3 x 0.3 = B3 | A4 x 0.4 = B4 |
| B1= | B2= | B3= | B4= |
| Degree of involvement as % foreach body region affected (scoreeach region with score between0-6) | 0 = None1 = 1-9%2 = 10-29%3 = 30-49%4 = 50-69%5 = 70-89%6 = 90-100% |  |  |  |  |
| For each body region multiply sub total B1, B2, B3 and B4 by | F |  |
|  | B1 x score = C1 | B2 x score = C2 | B3 x score = C3 | B4 x score = C4 |
| C1= | C2= | Cc3= | C4= |
| The patient's PASI score is the sum of C1+C2+C3+C4 | PASI= |

Shade in the affected areas

![](https://www.servicesaustralia.gov.au/sites/default/files/2025-10/images/4dc50d464ea2f85569e0eb11bf9a89bef9f316ea99d5cb6267fa7ae1a05a2452.jpg)